3/22/22 - Module 3: Study Planning and Communications

March 22, 2022

Study Planning and Communications will describe how to optimize the study question, design, and communications for diversity, equity, and inclusion in cancer clinical research. The impact of study design, eligibility criteria, feasibility assessment, site selection, decentralization of trials, and health literate and linguistically appropriate communications on recruitment and retention of underrepresented populations will be discussed.

Target Audience

This activity is intended for professionals and staff, leadership, and administration involved in Medical Oncology and Hematology with particular relevance to clinical research. The audience includes investigators, practicing providers, clinical trialists, clinical trials office staff, nurse practitioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, and other frontline staff; Regulatory/IRB committee members, and others with basic experience conducting clinical trials.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Consider measures to evaluate progress on DEI for participant representation in clinical research.
  2. Appreciate the importance of optimizing the study planning and design for DEI in clinical research, and specifically for cancer clinical research.
  3. Understand how study design, through eligibility criteria, feasibility assessments, site selection, and communications, can impact recruitment of underrepresented populations.

Additional Information

Provided by: 

The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center and Mass General Brigham

Please Note:

While attendees are strongly encouraged to attend the live instruction and discussion sessions for each module, attendees may access a pre-recorded version of the instruction session through this learning platform one day before the live instruction and discussion sessions. Each discussion session will also be recorded and posted to this learning platform one day following the live presentation. All recordings will be accessible until one week following the live presentation of Module 6.

For questions or assistance with any special needs regarding the training series, please contact the MRCT Center at:  MRCT@bwh.harvard.edu

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Course opens: 
Course expires: 
Event starts: 
03/22/2022 - 4:30pm EDT
Event ends: 
03/22/2022 - 6:00pm EDT

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1.50  AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation


Please login or register to take this course.

Required Hardware/software

These courses will be run via Zoom. The link to the zoom webinar will be sent to all attendees ahead of the session via email.